Infections Caused by Carbapenem-Resistant : An Update on Therapeutic Options (Q61806026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

title

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

0 references

0 references

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Po-Ren Hsueh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

author name string

Ya-Ting Chang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Shang-Yi Lin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Yen-Hsu Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

language of work or name

English

0 references

publication date

30 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

Frontiers in Microbiology

23 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

page(s)

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

23 April 2020

copyright license

start time

30 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan

1 reference

12 December 2020

Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model

1 reference

12 December 2020

Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae

1 reference

12 December 2020

Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.

1 reference

12 December 2020

Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.

1 reference

12 December 2020

Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections

1 reference

12 December 2020

ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates

1 reference

12 December 2020

Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model

1 reference

12 December 2020

How antibiotics kill bacteria: from targets to networks

1 reference

12 December 2020

In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase- producing Klebsiella pneumoniae

1 reference

12 December 2020

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

1 reference

12 December 2020

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

1 reference

12 December 2020

ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China

1 reference

12 December 2020

Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model

1 reference

12 December 2020

Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae

1 reference

12 December 2020

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline

1 reference

12 December 2020

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

1 reference

12 December 2020

Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes

1 reference

12 December 2020

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

1 reference

12 December 2020

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

1 reference

12 December 2020

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

1 reference

12 December 2020

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

1 reference

12 December 2020

Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit

1 reference

12 December 2020

Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.

1 reference

12 December 2020

Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae

1 reference

12 December 2020

Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers

1 reference

12 December 2020

KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients

1 reference

12 December 2020

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

1 reference

12 December 2020

Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens

1 reference

12 December 2020

Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence

1 reference

12 December 2020

Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients

1 reference

12 December 2020

Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance

1 reference

12 December 2020

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

1 reference

12 December 2020

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems

1 reference

12 December 2020

In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012.

1 reference

12 December 2020

Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011.

1 reference

12 December 2020

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria

1 reference

12 December 2020

Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis

1 reference

12 December 2020

Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains

1 reference

12 December 2020

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

1 reference

12 December 2020

Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.

1 reference

12 December 2020

The β-Lactams Strike Back: Ceftazidime-Avibactam

1 reference

12 December 2020

In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae

1 reference

12 December 2020

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

1 reference

12 December 2020

Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.

1 reference

12 December 2020

Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management

1 reference

12 December 2020

Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli

1 reference

12 December 2020

Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).

1 reference

12 December 2020

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

1 reference

12 December 2020

Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model

1 reference

12 December 2020

In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).

1 reference

12 December 2020

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis

1 reference

12 December 2020

New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance

1 reference

12 December 2020

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases

1 reference

12 December 2020

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii

1 reference

12 December 2020

Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin

1 reference

12 December 2020

In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.

1 reference

12 December 2020

Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

1 reference

12 December 2020

Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae

1 reference

12 December 2020

Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.

1 reference

12 December 2020

Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?

1 reference

12 December 2020

Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection

1 reference

12 December 2020

Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis

1 reference

12 December 2020

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections

1 reference

12 December 2020

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa

1 reference

12 December 2020

Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp).

1 reference

12 December 2020

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial

1 reference

12 December 2020

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

1 reference

12 December 2020

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

1 reference

12 December 2020

Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality

1 reference

12 December 2020

Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

1 reference

12 December 2020

Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae

1 reference

12 December 2020

The drug-resistant bacteria that pose the greatest health threats.

1 reference

12 December 2020

Therapeutic options for carbapenem-resistant Enterobacteriaceae infections

1 reference

12 December 2020

Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy

1 reference

12 December 2020

In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value

1 reference

12 December 2020

Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan

1 reference

12 December 2020

Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility

1 reference

12 December 2020

Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.

1 reference

12 December 2020

Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients

1 reference

12 December 2020

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

1 reference

12 December 2020

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

1 reference

12 December 2020

Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.

1 reference

12 December 2020

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

1 reference

12 December 2020

Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections

1 reference

12 December 2020

Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae.

1 reference

12 December 2020

Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens

1 reference

12 December 2020

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.

1 reference

12 December 2020

Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.

1 reference

12 December 2020

Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study

1 reference

12 December 2020

Double carbapenem therapy (DCT) for bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP): from test tube to clinical practice

1 reference

12 December 2020

The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan.

1 reference

12 December 2020

Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance

1 reference

12 December 2020

Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study

1 reference

12 December 2020

Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity

1 reference

12 December 2020

Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection

1 reference

12 December 2020

New agents for the treatment of infections with Gram-negative bacteria: Restoring the miracle or false dawn?

1 reference

12 December 2020

Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae

1 reference

12 December 2020

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, Against Carbapenem-Non-Susceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014-2016.

1 reference

12 December 2020

Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

1 reference

12 December 2020

Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects

1 reference

12 December 2020

Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia

1 reference

12 December 2020

Management of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: current evidence and future prospects.

1 reference

12 December 2020

Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

1 reference

12 December 2020

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

1 reference

12 December 2020

High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study

1 reference

12 December 2020

In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme

1 reference

12 December 2020

In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program

1 reference

12 December 2020

In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes

1 reference

12 December 2020

Critical Review of Double-Carbapenem Therapy for the Treatment of Carbapenemase-Producing Klebsiella pneumoniae

1 reference

12 December 2020

Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis

1 reference

12 December 2020

Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials

1 reference

12 December 2020

Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections

1 reference

12 December 2020

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates

1 reference

12 December 2020

Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms

1 reference

12 December 2020

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant

1 reference

12 December 2020

Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

1 reference

12 December 2020

Identifiers

DOI

10.3389/FMICB.2019.00080

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30761114%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

PubMed publication ID

30761114

1 reference